Aquestive reports study results for Anaphylm ahead of NDA resubmission

Go back to Aquestive reports study results for Anaphylm ahead of NDA resubmission
(NASDAQ: AQST) Delayed: 4.66 -0.16 (3.32%)
Previous Close $4.82    52 Week High
Open $5.00    52 Week Low
Day High $5.00    P/E N/A 
Day Low $4.62    EPS
Volume 2,529,933